Skip to main content
SpringerLink
Log in

Drugs should be considered potential culprits in patients who present with musculoskeletal disorders

  • Drug Reactions and Interaction
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I

References

  1. Bannwarth B. Drug-induced musculoskeletal disorders. Drug Saf 2007; 30(1): 27–46

    Article  PubMed  CAS  Google Scholar 

  2. Bannwarth B. Drug-induced rheumatic disorders. Rev Rhum Engl Ed 1996; 63(10): 639–47

    PubMed  CAS  Google Scholar 

  3. Cohen MG, Prowse MV. Drug-induced rheumatic syndromes: diagnosis, clinical features and management. Med Toxicol Adverse Drug Exp 1989; 4(3): 199–218

    Article  PubMed  CAS  Google Scholar 

  4. Adachi JD, Papaioannou A. Corticosteroid-induced osteoporosis: detection and management. Drug Saf 2001; 24(8): 607–24

    Article  PubMed  CAS  Google Scholar 

  5. Jones LC, Hungerford DS. Osteonecrosis: etiology, diagnosis, and treatment. Curr Opin Rheumatol 2004; 16(4): 443–9

    Article  PubMed  Google Scholar 

  6. Bannwarth B. Drug-induced myopathies. Expert Opin Drug Saf 2002; 1(1): 65–70

    Article  PubMed  CAS  Google Scholar 

  7. Reijman M, Bierma-Zeinstra SMA, Pols HA, et al. Is there an association between the use of different types of nonsteroidal anti-inflammatory drugs and radiologic progression of osteoarthritis? The Rotterdam study. Arthritis Rheum 2005 Oct; 52(10): 3137–42

    Article  PubMed  CAS  Google Scholar 

  8. Howell A, Cuzick J, Baum M, et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years adjuvant treatment of breast cancer. Lancet 2005; 365(9453): 60–2

    Article  PubMed  CAS  Google Scholar 

  9. Hawkins D, Evans J. Minimising the risk of heparin-induced osteoporosis during pregnancy. Expert Opin Drug Saf 2005; 4(3): 583–90

    Article  PubMed  CAS  Google Scholar 

  10. Gage BF, Birman-Deych E, Radford MJ, et al. Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2. Arch Intern Med 2006; 166(2): 241–6

    Article  PubMed  CAS  Google Scholar 

  11. Adami S, Zamberlan N. Adverse effects of bisphosphonates: a comparative review. Drug Saf 1996 Mar; 14(3): 158–70

    Article  PubMed  CAS  Google Scholar 

  12. Ensrud KE, Walczak TS, Blackwell T, et al. Antiepileptic drug increases rates of bone loss in older women: a prospective study. Neurology 2004; 62(11): 2051–7

    Article  PubMed  CAS  Google Scholar 

  13. Harrison BJ, Thomson W, Pepper L, et al. Patients who develop inflammatory polyarthitis (IP) after immunization are clinically indistinguishable from other patients with IP. Br J Rheumatol 1997; 36(3): 366–9

    Article  PubMed  CAS  Google Scholar 

  14. Avina-Zubieta JA, Johnson ES, Suarez-Almazor ME, et al. Incidence of myopathy in patients treated with antimalarials: report of three cases and a review of the literature. Br J Rheumatol 1995; 34(2): 166–70

    Article  PubMed  CAS  Google Scholar 

  15. Khaliq Y, Zhanel GG. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis 2003; 36(11): 1404–10

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drugs should be considered potential culprits in patients who present with musculoskeletal disorders. Drugs Ther. Perspect 23, 21–25 (2007). https://doi.org/10.2165/00042310-200723100-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200723100-00007

Search

Navigation